SF
CDMO

Synovus Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Synovus Financial’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,006
Closed -$13K – 1508
2020
Q2 		$13K Hold
2,006
– – ﹤0.01% 1176
2020
Q1 		$10K Hold
2,006
– – ﹤0.01% 1578
2019
Q4 		$15K Hold
2,006
– – ﹤0.01% 1153
2019
Q3 		$11K Hold
2,006
– – ﹤0.01% 1179
2019
Q2 		$11K Hold
2,006
– – ﹤0.01% 1106
2019
Q1 		$9K Hold
2,006
– – ﹤0.01% 1137
2018
Q4 		$8K Hold
2,006
– – ﹤0.01% 1130
2018
Q3 		$14K Hold
2,006
– – ﹤0.01% 1077
2018
Q2 		$8K Hold
2,006
– – ﹤0.01% 1092
2018
Q1 		$6K Buy
+2,006
New +$6.2K ﹤0.01% 1102
2017
Q3 		– Sell
-2,006
Closed -$9K – 771
2017
Q2 		$9K Hold
2,006
– – ﹤0.01% 742
2017
Q1 		$9K Buy
+2,006
New +$6.72K ﹤0.01% 972

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Synovus Financial's CDMO Position: Q3 2020 in Review

Synovus Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2020, closing a stake of 2,006 shares — an estimated $13K sold.

Synovus Financial first reported a position in CDMO in Q1 2017 and held it in 12 quarters. The position peaked at $15K in Q4 2019. 111 funds tracked by Wall St. Rank hold CDMO as of Q3 2020.

  • Synovus Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 2,006 Avid Bioservices, Inc. Common Stock shares in Q3 2020, an estimated $13K.
  • Synovus Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2017 and held it in 12 quarters.
  • Synovus Financial's Avid Bioservices, Inc. Common Stock position peaked at $15K in Q4 2019.
  • 111 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.